Bernhard Schölkopf holds keynote speech at online event “No one size fits all: Artificial Intelligence as Key Technology for Personalised Medicine”
Brussel/Tübingen – Artificial intelligence is one of the technologies that are key to Europe’s future. The areas of application are manifold, but not yet fully anchored in society. In the field of healthcare, the crucial role that data collection and analysis can play in the treatment of diseases has already been recognised. Personalised medicine is one out of many key applications of this modern data-driven approach to healthcare. Cross-disciplinary collaboration and a strong European network of AI hubs are needed to lever the full potential of AI.
Brussel/Tübingen – Artificial intelligence is one of the technologies that are key to Europe’s future. The areas of application are manifold, but not yet fully anchored in society. In the field of healthcare, the crucial role that data collection and analysis can play in the treatment of diseases has already been recognised. Personalised medicine is one out of many key applications of this modern data-driven approach to healthcare. Cross-disciplinary collaboration and a strong European network of AI hubs are needed to lever the full potential of AI.
The Cyber Valley ecosystem is one such powerful AI hub. Different universities and university hospitals, research institutes and industry are working closely together in an integrated approach. All partners have contributed to integrating this thriving research center into a globally recognised European network, the European Laboratory for Learning and Intelligent Systems, also known as Ellis.
Bernhard Schölkopf, Director of the Empirical Inference Department at the Max Planck Institute for Intelligent Systems, is the co-founder of Cyber Valley and of the Ellis Society. He held a keynote speech at an online event hosted by the Representation of the State of Baden-Württemberg to the European Union in Brussels. The event is among the first held after Germany took on the EU's rotating six-month presidency on July 1st. The panelists who contributed to the “No one size fits all: Artificial Intelligence as Key Technology for Personalised Medicine” event discussed the various interfaces between AI and medicine, the cooperation between science and industry as well as the future funding instruments for health and AI planned by the European Commission. Schölkopf particularly stressed the importance of creating an ideal research environment to help keep and attract the best AI talents from all over the world.
The event was moderated by Dr. Julia Stamm, Founder and Director of Berlin based Science Leads. She was also joined by
- Bodo Lehmann, Head of the Representation of the State of Baden-Württemberg to the European Union
- Theresia Bauer, Minister of Science, Research and Arts of the State of Baden-Württemberg,
- Dr. Karim Berkouk, Deputy Head of Unit Combatting Diseases, DG Research and Innovation, European Commission
- Dr. Nuria Oliver, Chief Data Scientist, Data-Pop Alliance, Member of the Board of ELLIS Society (European Laboratory for Learning and Intelligent Systems) and ELLIS Unit Alicante
- Dr. Oliver Stegle, Head of Division, Computational Genomics and Systems Genetics, German Cancer Research Center Heidelberg and European Molecular Biology Laboratory Heidelberg
